Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2021

Leo P, Chandramouli S, Farré X, Elliott R, Janowczyk A, Bera K, et al. Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2. Eur Urol Focus. 2021;7(4):722-732.

Marzo F, Milagro FI, Barrenetxe J, Díaz MT, J Martínez A. Azoxymethane-Induced Colorectal Cancer Mice Treated with a Polyphenol-Rich Apple Extract Show Less Neoplastic Lesions and Signs of Cachexia. Foods. 2021;10(4).

Patel A, Hoda SA, Swistel AJ. Mammary myofibroblastoma in a male: A classic case. Breast J. 2021;27(2):181-182.

Abuhelaiqa E, Snopkowski C, Li C, Salvatore S, Lee JR, Muthukumar T, et al. Validation of a noninvasive prognostic signature for allograft failure following BK virus associated nephropathy. Clin Transplant. 2021;35(2):e14200.

Shao R, Zhang Z, Xu Z, Ouyang H, Wang L, Ouyang H, et al. H3K36 methyltransferase NSD1 regulates chondrocyte differentiation for skeletal development and fracture repair. Bone Res. 2021;9(1):30.

Simonson PD, Wu Y, Wu D, Fromm JR, Lee AY. De Novo Identification and Visualization of Important Cell Populations for Classic Hodgkin Lymphoma Using Flow Cytometry and Machine Learning. Am J Clin Pathol. 2021.

Su H, Yang F, Fu R, Li X, French R, Mose E, et al. Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis. Cancer Cell. 2021;39(5):678-693.e11.

Gao J, Fu L, Lu X, Sukhanova M, Frankfurt O, Mohtashamian A, et al. Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of mutation and genetic complexity. Leuk Lymphoma. 2021:1-4.

Lange NW, Salerno DM, Berger K, Cushing MM, Brown RS. Management of Hepatic Coagulopathy in Bleeding and Nonbleeding Patients: An Evidence-Based Review. J Intensive Care Med. 2021;36(5):524-541.

Racine-Brzostek SE, Karbaschi M, Gaebler C, Klasse PJ, Yee J, Caskey M, et al. TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability. medRxiv. 2021.